83 related articles for article (PubMed ID: 8746195)
21. Grading, staging and scoring of left-ventricular hypertrophy, left-ventricular dilatation, asymptomatic left-ventricular dysfunction and chronic heart failure.
Field ML; Coats AJ
Eur Heart J; 1999 Sep; 20(17):1224-33. PubMed ID: 10454974
[No Abstract] [Full Text] [Related]
22. [Anatomopathological meeting: 60 years of hypertension and heart failure].
Di Paola G; Ré R; Grinberg A; Calbosa H; Adilardi AC; Semeniuk GB; Benchetrit G; Verón D; Carro G; Sabaté D; Finkielman S; De Feo GL; Bastaroli J; Paz LA
Medicina (B Aires); 2003; 63(1):54-60. PubMed ID: 12673964
[No Abstract] [Full Text] [Related]
23. Cardiac fibroblasts: from development to heart failure.
Moore-Morris T; Guimarães-Camboa N; Yutzey KE; Pucéat M; Evans SM
J Mol Med (Berl); 2015 Aug; 93(8):823-30. PubMed ID: 26169532
[TBL] [Abstract][Full Text] [Related]
24. Ontogeny of enhanced decorin levels and distribution within myocardium of failing hearts.
Medeiros DM; Velleman SG; Jarrold BB; Shiry LJ; Radin MJ; McCune SA
Connect Tissue Res; 2002; 43(1):32-43. PubMed ID: 12180266
[TBL] [Abstract][Full Text] [Related]
25. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
26. Determinants of left ventricular mass in hypertensive heart disease: a complex interplay between volume, pressure, systolic function and genes.
Perlini S
J Hypertens; 2007 Jul; 25(7):1341-2. PubMed ID: 17563551
[No Abstract] [Full Text] [Related]
27. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
[TBL] [Abstract][Full Text] [Related]
28. Fibroblasts: The arbiters of extracellular matrix remodeling.
DeLeon-Pennell KY; Barker TH; Lindsey ML
Matrix Biol; 2020 Sep; 91-92():1-7. PubMed ID: 32504772
[TBL] [Abstract][Full Text] [Related]
29. Extracellular matrix fibrotic markers in heart failure.
Zannad F; Rossignol P; Iraqi W
Heart Fail Rev; 2010 Jul; 15(4):319-29. PubMed ID: 19404737
[TBL] [Abstract][Full Text] [Related]
30. ECM remodeling in hypertensive heart disease.
Berk BC; Fujiwara K; Lehoux S
J Clin Invest; 2007 Mar; 117(3):568-75. PubMed ID: 17332884
[TBL] [Abstract][Full Text] [Related]
31. Activation and release of degradative proteinases within the myocardium are the trigger for ventricular remodeling in chronic heart failure.
Sackner-Bernstein JD
Med Hypotheses; 2002 Jan; 58(1):18-23. PubMed ID: 11863394
[TBL] [Abstract][Full Text] [Related]
32. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
[TBL] [Abstract][Full Text] [Related]
33. Microarray analysis of extracellular matrix genes expression in myocardium of mouse with Coxsackie virus B3 myocarditis.
Zhang ZC; Li SJ; Yang YZ; Chen RZ; Ge JB; Chen HZ
Chin Med J (Engl); 2004 Aug; 117(8):1228-31. PubMed ID: 15361300
[TBL] [Abstract][Full Text] [Related]
34. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
[TBL] [Abstract][Full Text] [Related]
35. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
36. Cardiac remodeling and failure From molecules to man (Part II).
Fedak PW; Verma S; Weisel RD; Li RK
Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
[TBL] [Abstract][Full Text] [Related]
37. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
[TBL] [Abstract][Full Text] [Related]
38. Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle.
Brattelid T; Qvigstad E; Birkeland JA; Swift F; Bekkevold SV; Krobert KA; Sejersted OM; Skomedal T; Osnes JB; Levy FO; Sjaastad I
J Mol Cell Cardiol; 2007 Dec; 43(6):767-79. PubMed ID: 17936780
[TBL] [Abstract][Full Text] [Related]
39. [Immune mechanisms in pathogenesis of chronic heart failure].
Egorova EN; Kalinkin MN; Mazur ES
Patol Fiziol Eksp Ter; 2012; (2):56-61. PubMed ID: 22708411
[TBL] [Abstract][Full Text] [Related]
40. Does Krüppel Like Factor 15 Play an Important Role in the Left Ventricular Hypertrophy of Patients with Type 2 Diabetes?
Zhao Y; Cai L
EBioMedicine; 2017 Jun; 20():17-18. PubMed ID: 28499925
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
